In days, domestic drugmakers are set to launch cheaper versions of semaglutide, the GLP-1 (glucagon-like peptide-1) therapy popular globally for weight management, following the drugs patent expiry in the country on Friday, 20 March
At TrimRx, we believe that understanding the science behind your treatment is the first step toward a successful health journey
Semaglutide is the active ingredient in both, but they are not the same product
The total cost is about $50 monthly, as little as one-tenth of what she would expect to pay their makers for full treatment
Research Use Only: This product is intended for laboratory research use only and is not for human consumption, diagnostic, or therapeutic use
The decision to continue or discontinue Mounjaro should be made collaboratively, considering the substantial metabolic benefits against theoretical concerns